Aclaris Therapeutics Inc. (ACRS)
NASDAQ: ACRS
· Real-Time Price · USD
1.86
0.02 (1.09%)
At close: Oct 03, 2025, 3:59 PM
1.84
-1.08%
After-hours: Oct 03, 2025, 06:20 PM EDT
1.09% (1D)
| Bid | 1.83 |
| Market Cap | 201.5M |
| Revenue (ttm) | 16.79M |
| Net Income (ttm) | -134.65M |
| EPS (ttm) | -1.55 |
| PE Ratio (ttm) | -1.2 |
| Forward PE | -3.47 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.9 |
| Volume | 842,946 |
| Avg. Volume (20D) | 1,073,770.3 |
| Open | 1.83 |
| Previous Close | 1.84 |
| Day's Range | 1.83 - 1.91 |
| 52-Week Range | 1.05 - 5.17 |
| Beta | 0.28 |
| Ex-Dividend Date | n/a |
About ACRS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACRS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACRS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAclaris Therapeutics Inc. is scheduled to release its earnings on
Nov 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-7.74%
Aclaris Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
4 months ago
+11.02%
Aclaris Therapeutics shares are trading higher after Wedbush initiated coverage on the stock with an Outperform rating and announced an $8 price target.
